Understanding the selectivity of a small molecule for its target(s) in cells is an important goal in chemical biology and drug discovery. One powerful way to address this question is with dominant negative (DN) mutants, in which an active site residue in the putative target is mutated. While powerful, this approach is less straightforward for allosteric sites. Here, we introduce tryptophan scanning mutagenesis as an expansion of this idea. As a test case, we focused on the challenging drug target, heat shock cognate protein 70 (Hsc70), and its allosteric inhibitor JG-98. Structure-based modelling predicted that mutating Y149W in human Hsc70 or Y145W in the bacterial ortholog DnaK would place an indole side chain into the allosteric pocket normally occupied by the compound. Indeed, we found that the tryptophan mutants acted as if they were engaged with JG-98. We then used DnaK Y145W to suggest that this protein may be an anti-bacterial target. Indeed, we found that DnaK inhibitors have minimum inhibitory concentration (MIC) values <0.125 μg mL-1 against several pathogens, including multidrug-resistant Staphylococcus aureus (MRSA) strains. We propose that tryptophan scanning mutagenesis may provide a distinct way to address the important problem of target engagement.
|Number of pages||13|
|State||Published - Feb 21 2020|
Bibliographical noteFunding Information:
The authors thank Oren Rosenberg (UCSF) for supplying the PBAD vector and Mathias Meyer for supplying the DdnaK strain BB1994. We also thank Oliver Gestwicki for editing the gures. This work was supported by grants from the NIH (R01NS059690; J. E. G.) and AIRC (IG20019; G. C.).
© The Royal Society of Chemistry.
ASJC Scopus subject areas
- Chemistry (all)